1. Clinical efficacy and safety of pemetrexed with or without either Bevacizumab or Pembrolizumab in patients with metastatic nonsquamous non–small cell carcinoma. Issue 1 (20th April 2022) Authors: Kwok, Wang Chun; Cheong, Tan Fong; Chiang, Ka Yan; Ho, James Chung Man; Lam, David Chi Leung; Ip, Mary Sau Man; Tam, Terence Chi Chun Journal: Asia-Pacific journal of clinical oncology Issue: Volume 19:Issue 1(2023) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. (February 2021) Authors: Kwok, Wang Chun; Cheong, Tan Fong; Chiang, Ka Yan; Ho, James Chung Man; Lam, David Chi Leung; Ip, Mary Sau Man; Tam, Terence Chi Chun Journal: Lung cancer Issue: Volume 152(2021) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗